Padilla, Jenelyn .

HRN: 21-51-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2022
CEFUROXIME 500MG (TAB)
07/02/2022
07/08/2022
PO
500mg
BID
Threatened Abortion
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamReproductive Tract    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: